0001140361-17-012884.txt : 20170321
0001140361-17-012884.hdr.sgml : 20170321
20170321202322
ACCESSION NUMBER: 0001140361-17-012884
CONFORMED SUBMISSION TYPE: 4/A
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170223
FILED AS OF DATE: 20170321
DATE AS OF CHANGE: 20170321
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: REPLIGEN CORP
CENTRAL INDEX KEY: 0000730272
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 042729386
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 41 SEYON STREET
STREET 2: BUILDING 1, SUITE 100
CITY: WALTHAM
STATE: MA
ZIP: 02453
BUSINESS PHONE: 7814499560
MAIL ADDRESS:
STREET 1: 41 SEYON STREET
STREET 2: BUILDING 1, SUITE 100
CITY: WALTHAM
STATE: MA
ZIP: 02453
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Benjamin Howard
CENTRAL INDEX KEY: 0001393547
FILING VALUES:
FORM TYPE: 4/A
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-14656
FILM NUMBER: 17705339
MAIL ADDRESS:
STREET 1: 401 MARRETT ROAD
CITY: LEXINGTON
STATE: MA
ZIP: 02421
4/A
1
doc1.xml
FORM 4/A
X0306
4/A
2017-02-23
2017-03-01
0
0000730272
REPLIGEN CORP
RGEN
0001393547
Benjamin Howard
C/O REPLIGEN CORPORATION
41 SEYON ST, BLDG 1, STE 100
WALTHAM
MA
02453
0
1
0
0
VP Business Development
Stock Option (Right to Buy)
32.40
2017-02-23
4
A
0
9012
0
A
2027-02-23
Common Stock
9012
9012
D
The shares vest in equal annual installments over a three-year period beginning on the first anniversary of the grant date.
This Form 4/A amends a Form 4 filed on 3/1/17 to correct a typographical error in Table II, column 2.
/s/ Jeffrey P. Leduc (Attorney in Fact)
2017-03-21